| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.63▲ | 11.62▲ | 11.61▲ | 11.49▲ | 11.59▲ |
| MA10 | 11.62▲ | 11.59▲ | 11.57▲ | 11.53▲ | 11.68▼ |
| MA20 | 11.59▲ | 11.54▲ | 11.49▲ | 11.60▲ | 11.73▼ |
| MA50 | 11.50▲ | 11.48▲ | 11.49▲ | 11.72▼ | 11.61▲ |
| MA100 | 11.48▲ | 11.53▲ | 11.55▲ | 11.74▼ | 11.81▼ |
| MA200 | 11.52▲ | 11.61▲ | 11.65▼ | 11.59▲ | 12.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.010▲ | 0.021▲ | 0.002▲ | -0.032▼ |
| RSI | 85.109▲ | 79.381▲ | 73.639▲ | 51.343▲ | 49.066▼ |
| STOCH | 100.000▲ | 100.000▲ | 100.000▲ | 32.066 | 39.345 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -26.667 | -46.774 |
| CCI | 124.444▲ | 132.911▲ | 130.188▲ | 53.654 | -103.520▼ |
|
Monday, November 03, 2025 09:05 AM
(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool. The drugmaker said 99.36% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/11/25 | 11.56 | 11.65 | 11.54 | 11.64 | 385,600 |
| 24/11/25 | 11.42 | 11.56 | 11.42 | 11.56 | 515,173 |
| 21/11/25 | 11.35 | 11.4398 | 11.31 | 11.43 | 285,387 |
| 20/11/25 | 11.53 | 11.5499 | 11.3245 | 11.35 | 356,934 |
| 19/11/25 | 11.54 | 11.54 | 11.44 | 11.46 | 379,041 |
| 18/11/25 | 11.50 | 11.50 | 11.405 | 11.46 | 628,533 |
| 17/11/25 | 11.63 | 11.63 | 11.4901 | 11.53 | 254,251 |
| 14/11/25 | 11.55 | 11.61 | 11.52 | 11.59 | 395,600 |
| 13/11/25 | 11.76 | 11.76 | 11.57 | 11.59 | 326,449 |
| 12/11/25 | 11.71 | 11.7298 | 11.68 | 11.71 | 284,230 |
|
|
||||
|
|
||||
|
|